Cargando…
The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study
BACKGROUND: Most people with sore throat do not benefit from antibiotic treatment, but nearly three-quarters of those presenting in primary care are prescribed antibiotics. A test that is predictive of bacterial infection could help guide antibiotic prescribing. Calprotectin is a biomarker of neutro...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330218/ https://www.ncbi.nlm.nih.gov/pubmed/31964636 http://dx.doi.org/10.3399/bjgpopen20X101006 |
_version_ | 1783553068622675968 |
---|---|
author | Schofield, Behnaz Gregory, Clive Gal, Micaela Gillespie, David Naik, Gurudutt Hay, Alastair Francis, Nick |
author_facet | Schofield, Behnaz Gregory, Clive Gal, Micaela Gillespie, David Naik, Gurudutt Hay, Alastair Francis, Nick |
author_sort | Schofield, Behnaz |
collection | PubMed |
description | BACKGROUND: Most people with sore throat do not benefit from antibiotic treatment, but nearly three-quarters of those presenting in primary care are prescribed antibiotics. A test that is predictive of bacterial infection could help guide antibiotic prescribing. Calprotectin is a biomarker of neutrophilic inflammation, and may be a useful marker of bacterial throat infections. AIM: To assess the feasibility of measuring calprotectin from throat swabs, and assess whether individuals with sore throats likely to be caused by streptococcal infections have apparently higher throat calprotectin levels than other individuals with sore throat and healthy volunteers. DESIGN & SETTING: A proof of concept case–control study was undertaken, which compared primary care patients with sore throats and healthy volunteers. METHOD: Baseline characteristics and throat swabs were collected from 30 primary care patients with suspected streptococcal sore throat, and throat swabs were taken from 10 volunteers without sore throat. Calprotectin level determination and rapid antigen streptococcal testing were conducted on the throat swab eluents. Calprotectin levels in the following groups were compared: volunteers without a sore throat; all patients with a sore throat; patients with a sore throat testing either negative or positive for streptococcal antigen; and those with lower and higher scores on clinical prediction rules for streptococcal sore throat. RESULTS: Calprotectin was detected in all throat swab samples. Mean calprotectin levels were numerically higher in patients with sore throat compared with healthy volunteers, and sore throat patients who had group A streptococci antigen detected compared with those who did not. CONCLUSION: Calprotectin can be measured from throat swab samples and levels are consistent with the hypothesis that streptococcal infection leads to higher throat calprotectin levels. This hypothesis will be tested in a larger study. |
format | Online Article Text |
id | pubmed-7330218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Royal College of General Practitioners |
record_format | MEDLINE/PubMed |
spelling | pubmed-73302182020-07-07 The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study Schofield, Behnaz Gregory, Clive Gal, Micaela Gillespie, David Naik, Gurudutt Hay, Alastair Francis, Nick BJGP Open Research BACKGROUND: Most people with sore throat do not benefit from antibiotic treatment, but nearly three-quarters of those presenting in primary care are prescribed antibiotics. A test that is predictive of bacterial infection could help guide antibiotic prescribing. Calprotectin is a biomarker of neutrophilic inflammation, and may be a useful marker of bacterial throat infections. AIM: To assess the feasibility of measuring calprotectin from throat swabs, and assess whether individuals with sore throats likely to be caused by streptococcal infections have apparently higher throat calprotectin levels than other individuals with sore throat and healthy volunteers. DESIGN & SETTING: A proof of concept case–control study was undertaken, which compared primary care patients with sore throats and healthy volunteers. METHOD: Baseline characteristics and throat swabs were collected from 30 primary care patients with suspected streptococcal sore throat, and throat swabs were taken from 10 volunteers without sore throat. Calprotectin level determination and rapid antigen streptococcal testing were conducted on the throat swab eluents. Calprotectin levels in the following groups were compared: volunteers without a sore throat; all patients with a sore throat; patients with a sore throat testing either negative or positive for streptococcal antigen; and those with lower and higher scores on clinical prediction rules for streptococcal sore throat. RESULTS: Calprotectin was detected in all throat swab samples. Mean calprotectin levels were numerically higher in patients with sore throat compared with healthy volunteers, and sore throat patients who had group A streptococci antigen detected compared with those who did not. CONCLUSION: Calprotectin can be measured from throat swab samples and levels are consistent with the hypothesis that streptococcal infection leads to higher throat calprotectin levels. This hypothesis will be tested in a larger study. Royal College of General Practitioners 2020-01-22 /pmc/articles/PMC7330218/ /pubmed/31964636 http://dx.doi.org/10.3399/bjgpopen20X101006 Text en Copyright © 2020, The Authors https://creativecommons.org/licenses/by/4.0/ This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/ ) |
spellingShingle | Research Schofield, Behnaz Gregory, Clive Gal, Micaela Gillespie, David Naik, Gurudutt Hay, Alastair Francis, Nick The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study |
title | The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study |
title_full | The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study |
title_fullStr | The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study |
title_full_unstemmed | The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study |
title_short | The feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group A streptococcus: a case–control feasibility study |
title_sort | feasibility of measuring calprotectin from a throat swab as a marker of infections caused by group a streptococcus: a case–control feasibility study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330218/ https://www.ncbi.nlm.nih.gov/pubmed/31964636 http://dx.doi.org/10.3399/bjgpopen20X101006 |
work_keys_str_mv | AT schofieldbehnaz thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT gregoryclive thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT galmicaela thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT gillespiedavid thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT naikgurudutt thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT hayalastair thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT francisnick thefeasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT schofieldbehnaz feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT gregoryclive feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT galmicaela feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT gillespiedavid feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT naikgurudutt feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT hayalastair feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy AT francisnick feasibilityofmeasuringcalprotectinfromathroatswabasamarkerofinfectionscausedbygroupastreptococcusacasecontrolfeasibilitystudy |